HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B
about
Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyClinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model.Targeting HER2 in Advanced Breast Cancer.Boolean network modeling in systems pharmacology.A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types.Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer
P2860
HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@ast
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@en
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@nl
type
label
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@ast
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@en
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@nl
prefLabel
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@ast
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@en
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@nl
P2093
P2860
P3181
P1476
HER2+ Cancer Cell Dependence o ...... sion of EGFR, ERBB3 and CDKN1B
@en
P2093
Birgit Schoeberl
Charlotte F McDonagh
Daniel C Kirouac
Johanna Lahdenranta
Matthew D Onsum
Ulrik B Nielsen
P2860
P304
P3181
P356
10.1371/JOURNAL.PCBI.1004827
P407
P577
2016-04-01T00:00:00Z